These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 3334993

  • 1. Correlation of vascular permeability and blood flow with monoclonal antibody uptake by human Clouser and renal cell xenografts.
    Sands H, Jones PL, Shah SA, Palme D, Vessella RL, Gallagher BM.
    Cancer Res; 1988 Jan 01; 48(1):188-93. PubMed ID: 3334993
    [Abstract] [Full Text] [Related]

  • 2. Pretargeting with bispecific anti-renal cell carcinoma x anti-DTPA(In) antibody in 3 RCC models.
    van Schaijk FG, Oosterwijk E, Molkenboer-Kuenen JD, Soede AC, McBride BJ, Goldenberg DM, Oyen WJ, Corstens FH, Boerman OC.
    J Nucl Med; 2005 Mar 01; 46(3):495-501. PubMed ID: 15750164
    [Abstract] [Full Text] [Related]

  • 3. Monoclonal antibodies to human renal cell carcinoma: recognition of shared and restricted tissue antigens.
    Vessella RL, Moon TD, Chiou RK, Nowak JA, Arfman EW, Palme DF, Peterson GA, Lange PH.
    Cancer Res; 1985 Dec 01; 45(12 Pt 1):6131-9. PubMed ID: 3904980
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Radioimmunodetection of small human tumor xenografts in spleen of athymic mice by monoclonal antibodies.
    Shah SA, Gallagher BM, Sands H.
    Cancer Res; 1985 Nov 01; 45(11 Pt 2):5824-9. PubMed ID: 4053053
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Localization of human renal cell carcinoma xenografts with a tumor-preferential monoclonal antibody.
    Chiou RK, Vessella RL, Elson MK, Clayman RV, Gonzalez-Campoy JM, Klicka MJ, Shafer RB, Lange PH.
    Cancer Res; 1985 Dec 01; 45(12 Pt 1):6140-6. PubMed ID: 2415239
    [Abstract] [Full Text] [Related]

  • 9. Antibody fragments in tumor pretargeting. Evaluation of biotinylated Fab' colocalization with recombinant streptavidin and avidin.
    Wilbur DS, Hamlin DK, Vessella RL, Stray JE, Buhler KR, Stayton PS, Klumb LA, Pathare PM, Weerawarna SA.
    Bioconjug Chem; 1996 Dec 01; 7(6):689-702. PubMed ID: 8950488
    [Abstract] [Full Text] [Related]

  • 10. Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms.
    Yokota T, Milenic DE, Whitlow M, Wood JF, Hubert SL, Schlom J.
    Cancer Res; 1993 Aug 15; 53(16):3776-83. PubMed ID: 8339291
    [Abstract] [Full Text] [Related]

  • 11. Uptake and distribution of specific and control monoclonal antibodies in subcutaneous xenografts following intratumor injection.
    Rowlinson-Busza G, Bamias A, Krausz T, Epenetos AA.
    Cancer Res; 1991 Jun 15; 51(12):3251-6. PubMed ID: 2040000
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon gamma.
    Gastl G, Ebert T, Finstad CL, Sheinfeld J, Gomahr A, Aulitzky W, Bander NH.
    J Urol; 1996 Jan 15; 155(1):361-7. PubMed ID: 7490887
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hyaluronidase-induced periodic modulation of the interstitial fluid pressure increases selective antibody uptake in human osteosarcoma xenografts.
    Brekken C, Hjelstuen MH, Bruland ØS, de Lange Davies C.
    Anticancer Res; 2000 Jan 15; 20(5B):3513-9. PubMed ID: 11131655
    [Abstract] [Full Text] [Related]

  • 16. Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature.
    Tijink BM, Neri D, Leemans CR, Budde M, Dinkelborg LM, Stigter-van Walsum M, Zardi L, van Dongen GA.
    J Nucl Med; 2006 Jul 15; 47(7):1127-35. PubMed ID: 16818947
    [Abstract] [Full Text] [Related]

  • 17. A human tumor xenograft model of therapy with a bispecific monoclonal antibody targeting c-erbB-2 and CD16.
    Weiner LM, Holmes M, Adams GP, LaCreta F, Watts P, Garcia de Palazzo I.
    Cancer Res; 1993 Jan 01; 53(1):94-100. PubMed ID: 8093231
    [Abstract] [Full Text] [Related]

  • 18. Radiolocalization of human mammary tumors in athymic mice by a monoclonal antibody.
    Colcher D, Zalutsky M, Kaplan W, Kufe D, Austin F, Schlom J.
    Cancer Res; 1983 Feb 01; 43(2):736-42. PubMed ID: 6848189
    [Abstract] [Full Text] [Related]

  • 19. Improved biodistribution of 125I-labeled anti-Tac disulfide-stabilized Fv fragment by blocking its binding to the alpha subunit of the interleukin 2 receptor in the circulation with preinjected humanized anti-Tac IgG.
    Kobayashi H, Yoo TM, Drumm D, Kim MK, Sun BF, Le N, Webber KO, Pastan I, Waldmann TA, Paik CH, Carrasquillo JA.
    Cancer Res; 1997 May 15; 57(10):1955-61. PubMed ID: 9157991
    [Abstract] [Full Text] [Related]

  • 20. Modulation of human tumor antigen expression.
    Greiner JW, Hand PH, Colcher D, Weeks M, Thor A, Noguchi P, Pestka S, Schlom J.
    J Lab Clin Med; 1987 Mar 15; 109(3):244-61. PubMed ID: 2434589
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.